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Abstract
A randomized controlled field trial to evaluate the effectiveness of a single oral dose of 30 mg/kg of oxfendazole (OFZ)
treatment for control of porcine cysticercosis was conducted in 4 rural villages of Ango ´nia district, north-western
Mozambique. Two hundred and sixteen piglets aged 4 months were selected and assigned randomly to OFZ treatment or
control groups. Fifty-four piglets were treated at 4 months of age (T1), while another 54 piglets were treated at 9 months of
age (T2) and these were matched with 108 control pigs from the same litters and raised under the same conditions. Baseline
data were collected on the prevalence of porcine cysticercosis using antigen ELISA (Ag-ELISA), as well as knowledge and
practices related to Taenia solium transmission based on questionnaire interviews and observations. All animals were
followed and re-tested for porcine cysticercosis by Ag-ELISA at 9 and 12 months of age when the study was terminated.
Overall prevalence at baseline was 5.1% with no significant difference between groups. At the end of the study, 66.7% of
the controls were found positive, whereas 21.4% of the T1 and 9.1% of the T2 pigs were positive, respectively. Incidence
rates of porcine cysticercosis were lower in treated pigs as compared to controls. Necropsy of 30 randomly selected animals
revealed that viable cysts were present in none (0/8) of T2 pigs, 12.5% (1/8) of T1 pigs and 42.8% (6/14) of control pigs.
There was a significant reduction in the risk of T. solium cysticercosis if pigs were treated with OFZ either at 4 months
(OR=0.14; 95% CI: 0.05–0.36) or at 9 months of age (OR=0.05; 95% CI: 0.02–0.16). Strategic treatment of pigs in endemic
areas should be further explored as a means to control T. solium cysticercosis/taeniosis.
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Introduction
Taenia solium is the etiologic agent of cysticercosis, an important
zoonotic infection involving humans and pigs. The life cycle of this
parasite includes pigs as the normal intermediate hosts, harbouring
the larval cysts in many parts of the body causing cysticercosis, and
humans as definitive hosts, harbouring the adult tapeworm in the
intestines causing a condition known as taeniosis. Humans are
accidental hosts of cysticerci after ingestion of T. solium eggs from
the environment and develop the cysts in their tissues and organs,
with the central nervous system (CNS) being a common site of cyst
location resulting in neurocysticercosis [1,2]. Cysticercosis in pigs
is endemic in many developing countries of Latin America [3,4],
Africa [5], and Asia [6], where it causes important economic losses
resulting from condemnation of infected pork [7,8]. The disease
has been declared preventable and potentially eradicable [9], but
in many developing countries it is still a major constraint in pig
production mainly due to lack of awareness about its extent, poor
socioeconomic conditions and the absence of suitable diagnostic
tools and control strategies [10–13].
Currently, the diagnosis of porcine cysticercosis in live animals
is based on lingual examination that is sensitive only in detecting
moderate to heavy infections [14]. Reliable serological tests based
on detection of specific antibody and antigen have been developed
and proved very useful in confirming diagnosis [15,16]. Among
them the Ag-ELISA has been reported to have high specificity
(86.7%) and sensitivity (94.7%), even detecting circulating antigens
in pigs harbouring one single T. solium cyst [15,17] or detecting
circulating antigens as early as two to six weeks after infection [17].
However, the detection of circulating antigens technique is unable
to distinguish T. solium from T. hydatigena cysticerci, and where the
later parasite is highly prevalent the method may be of limited use
[18].
Control measures such as improved animal husbandry practic-
es, efficient meat inspection procedures, and health education
about hygiene and sanitation have been of limited impact in
developing countries where pigs are mainly raised by poor
smallholder farmers and marketing of pork is not controlled
[19]. However, control of cysticercosis should be possible by
eliminating the infection from either pigs or humans, or both for
an extended period. Since the pig constitutes a vital link in the
transmission cycle of T. solium [20,21], an effective treatment of
infected pigs should interrupt the transmission cycle. Oxfendazole
(methyl 5[6]-phenylsulfinyl-2-benzimidazolecarbamate) (OFZ), a
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ruminants for treatment and control of gastro-intestinal round-
worms, lungworms and certain tapeworms, has been shown to kill
all viable T. solium cysticerci in muscles but ineffective against brain
cysts in infected pigs [22–25]. Pigs treated with OFZ were
reported to be refractory to re-infection even in the event of
ongoing exposure to T. solium eggs [25]. More importantly,
carcasses from treated pigs were reported to have a normal
appearance suitable for human consumption after 3–6 months
depending on intensity of infection [23,24]. Surveillance for
detection of infected pigs followed by treatment with OFZ could
reduce the flow of contaminated pork into the market [22,23].
Mass porcine chemotherapy with OFZ could, therefore, also be a
useful strategy to control T. solium, by providing health as well as
economic benefits for rural poor smallholder communities.
However, most studies that have addressed the use of OFZ
against porcine cysticercosis thus far have mainly focused on
efficacy of the drug as opposed to its effectiveness. Therefore, the
present study aimed to evaluate the effectiveness of a single oral
dose of 30 mg/kg of OFZ against T. solium cysticercosis in pigs
reared in smallholder farming systems in a highly endemic area.
Materials and Methods
Study area
The study was conducted in Ango ´nia district located in north-
western Mozambique between latitude 14.27uS and 15.28uS, and
longitude 33.59uE and 34.38uE. The district is characterized by a
humid climate with a rainy season extending from November to
mid-March and the dry period from April to October. Four
villages were selected randomly from a group of 11 villages within
the district with a known high prevalence of porcine cysticercosis
[26]. A preliminary visit was made to the selected villages to
evaluate villagers’ willingness to collaborate in a longitudinal study
for control of porcine cysticercosis.
Experimental study design
A randomized field study with a control group was conducted,
between August 2008 and May 2009, to evaluate the effectiveness
of a single oral dose of 30 mg/kg of OFZ treatment against T.
solium cysticercosis by comparing the prevalence and incidence of
porcine cysticercosis between treatment and control groups. Fifty-
four pig litters from same number of households, comprising a
total of 216 piglets aged 4 months were selected for the study and
followed to the age of 12 months. All piglets were identified and
ear-tagged with consecutive numbers and each litter in a
household was divided into three groups by randomization. The
Group 1 piglets (n=54) were treated with OFZ at 4 months of age
(T1), Group 2 (n=54) was treated at 9 months of age (T2) while
Group 3 (n=108) served as non-treated controls (C). At the end of
the trial, a total of 30 randomly selected pigs (8 from each of the
OFZ-treatment groups and 14 from the control group) were
purchased from villagers, slaughtered locally and dissected for
assessment of T. solium cysticerci.
Blood collection
Blood was collected from all animals in both treatment and
control groups in three sampling rounds (4, 9 and 12 months of
age), and information regarding sampling date, household, village,
sex and age was recorded. Blood samples were obtained from the
cranial vena cava into plain vacutainers tubes and allowed to clot
at 4uC. Serum was obtained by centrifugation, dispensed into 2 ml
aliquots, stored in labelled vials and kept at 220uC until use.
Oxfendazole treatment of experimental animals
The animals of the two OFZ-treatment groups were first weighed
and later given orally a single dose of 30 mg/kg OFZ (Oxfen-C, Lot
800869, Bayer, Isando,South Africa) as a suspension (concentration
of 9.06%), while the control group did not receive any treatment.
The drug was administered through a dispensing tube attached to a
15 ml drench gun. The pig was firmly restrained and a pig snare
was used to stabilize the head. The end of the dispensing tube of the
drench gun was passed gently, but firmly, over the back of the
tongue to allow the pig to swallow the dispensed suspension and
ensure the complete delivery of the drug.
Serological detection of circulating antingens of T. solium
cysticerci (Ag-ELISA)
The Ag-ELISA was performed as described by Brandt and
others [27] and modified by Dorny and others [15]. Briefly, the
serum samples were pre-treated using trichloroacetic acid (TCA)
and used in ELISA at a final dilution of 1/4. Two monoclonal
antibodies (MoAb) used in a sandwich ELISA were B158C11A10
(Lot K, ITM, Antwerp, Belgium) diluted at 5 mg/ml in carbonate
buffer (0.06M/pH 9.6) for coating and a biotinylated MoAb
B60H8A4 (Lot 28, ITM, Antwerp, Belgium) diluted at 1.25 mg/ml
in phosphate buffered saline-Tween 20 (PBS-T20)+1% new born
calf serum (NBCS) as detector antibody. The incubation was
carried out at 37uC on a shaker for 30 min for the coating of the
first MoAb and for 15 min for all subsequent steps. The substrate
solution consisting of ortho phenylenediamine (OPD) and H2O2
was added and incubated without shaking at 30uC for 15 min. To
stop the reaction, 50 mlo fH 2SO4 (4N) was added to each well.
The plates were read using an ELISA reader at 492 nm. Sera from
two known positive pigs (confirmed at slaughter) were used as
positive control. To determine the cut-off, the optical density (OD)
of each serum sample was compared with a series of 8 reference
negative serum samples at a probability level of 0.1% using a
modified Student’s t-test [28].
Carcass dissection for assessment of porcine cysticercosis
Carcass dissection was performed as described by Phiri et al [14]
with slight modifications. Briefly, skeletal muscle groups were
Author Summary
Porcine cysticercosis is an infection of pigs caused by the
larval stage of Taenia solium, a tapeworm that causes
taeniosis in humans. The disease is very common in
developing countries where it is a serious public health risk
and causes significant economic losses in pig production.
Many control strategies in developing countries have been
of limited impact mainly due to poor socioeconomic and
sanitary conditions. An effective treatment of infected pigs
using inexpensive drugs may have potential as a long term
control tool. We performed a randomized controlled trial
to evaluate the effectiveness of oxfendazole treatment for
control of porcine cysticercosis. We evaluated the preva-
lence and incidence of the disease in groups of pigs
treated at 4 and 9 months of age and untreated pigs. We
found that the prevalence and incidence of the disease in
treated pigs was significantly lower than in untreated pigs.
We conclude that treatment of pigs with oxfendazole in
the last part of the fattening period is cost-effective in
controlling porcine cysticercosis in endemic low-income
areas but should be integrated with other control
measures.
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heart, tongue, head and neck muscles, psoas muscles, diaphragm,
lungs, kidneys, liver and brains. Dissection was done in such a way
that all fully developed cysts could be revealed (i.e. each slice was
about 0.5 cm thick). Animals were considered infected if viable
cysts were found in the carcass.
Data analysis
Data were entered and analysed using STATA version 9.1
(Stata Corporation, College Station, TX, USA). Prevalence
estimates were calculated for pigs that were bled in each sampling
round. Incidence was estimated as the number of new cases
occurred per unit of animal time at risk, during a period between
two consecutive sampling rounds. Confidence intervals were
calculated for prevalence and incidence of porcine cysticercosis
in both treatment and control groups. Chi-square test and
statistical comparison of rates were used to compare the
prevalence and incidence, respectively. Logistic regression models
were fitted to examine the role of factors potentially associated to
prevalence of porcine cysticercosis. Examined factors included
treatment time, sex of the pig, pig husbandry practices and village.
The statistical significance level was set at 5%.
Ethics statement
The study was conducted with ethical approval from the
scientific board of the Veterinary Faculty, Eduardo Mondlane
University. All animals were handled in strict accordance with
good animal practice as defined by the OIE’s Terrestrial Animal
Health Code for the use of animals in research and education.
Study permissions were obtained from the Livestock National
Directorate, village leaders and pig owners. Due to high level of
illiteracy among villagers, an oral consent was obtained from pig
farmers in the presence of a witness, who signed on their behalf. At
the end of the trial all animals were treated with OFZ, and pig
farmers were informed not to slaughter their animals before 4
weeks after the treatment.
Results
Experimental animals and sampling
All examined pigs (n=216) were of the local breed (Landim),
mostly males (55%) and the majority (93.1%) were deliberately left
to roam freely. A total of 570 samples were collected along three
sampling rounds from 216 pigs. From these animals, 32 (14.8%)
were sampled once, 184 (85.2%) were sampled twice, and 170
(78.7%) were sampled three times. Altogether 46 animals were lost
to follow-up, out of which 24 (22.2%) were from the control group,
12 (22.2%) from T1 group and 10 (18.5%) were from T2 group.
The main reasons for losses of animals to follow-up were death,
sale or refusals to allow sampling due to absence of the head of the
household. Overall baseline prevalence at 4 months of age was
5.1% (95% CI=2.6%–8.9%) and did not differ significantly
(p.0.05) among comparison groups.
Measurement of treatment effectiveness
Prevalence. Comparison of prevalence between treatment
and control groups showed similar results at baseline but lower in
both treatment groups at the end of the study (Table 1). A
significant increase (p,0.001) in the prevalence of porcine
cysticercosis was observed in the control group during all the
study period. A similar increasing trend was also observed in T1
pigs although the prevalence was significantly lower (p,0.001)
compared to the control group at 12 months of age. In T2 pigs, the
prevalence of porcine cysticercosis increased significantly
(p,0.001) from 4 to 9 months of age, but was significantly
reduced (p,0.01) at 12 months of age. Although the prevalence
was higher in the T1 group than in the T2 group at month 12 of
age, the difference was not statistically significant (p=0.11).
Incidence. At the baseline, a total of 205 pigs from all groups
were negative by Ag-ELISA, thus being at risk of infection
Comparison of incidence between treatment and control groups
showed lower incidence rates (p,0.05) in both treatment groups
during the follow-up period (Table 2). In addition, all infected pigs
at the time of treatment were found negative in the subsequent
sampling round. However, apart from the new cases observed
after treatment and losses to follow-up, 33.3% (n=1) of infected
pigs treated at 4 months of age were found re-infected at 12
months of age, whereas all (n=18) infected pigs treated at 9
months of age were found free of T. solium circulating antigens at
the age of 12 months.
Cyst assessment. Carcass dissection of the 30 randomly
selected pigs at the end of the study revealed that 12.5% (1/8) of
T1 pigs and 42.8% (6/14) of control pigs had viable cysts in
different organs and muscles, whereas this was the case in none of
the T2 pigs (Table 3). Cysts were frequently localized in group
muscles (82.1%), heart (5.6%), tongue (4.8%), diaphragm (4.5%)
and brain (2.8%). However, brain cysts were only observed in
some (n=3) control pigs. The number of cysts ranged between 17
and 113 with an average of 50 cysts per pig. All pigs with T. solium
cysticerci at necropsy were also found positive by Ag-ELISA.
Table 1. Prevalence of porcine cysticercosis.
Age Control group T1 group T2 group
Number tested Prevalence (%) Number tested Prevalence (%) Number tested Prevalence (%)
4 months 108 5.6 54 5.5 54 3.7
9 months 90 33.3 44 13.6 50 36.0
12 months 84 66.7 42 21.4 44 9.1
doi:10.1371/journal.pntd.0001651.t001
Table 2. Incidence rates of porcine cysticercosis.
Period Number of cases per 100 pigs-month
Control group T1 group T2 group
1 (between 1
st and 2
nd
sampling)
2.2 1.1 2.9
2 (between 2
nd and 3
rd
sampling)
11.5 2.1 1.6
doi:10.1371/journal.pntd.0001651.t002
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ysis of the effect of treatment (at the end of experiment) adjusted
for sex of the pig, husbandry system and village (Table 4) revealed
a significant (p,0.001) decrease in the risk for porcine cysticercosis
infection at the age of 12 months if pigs were treated with OFZ
either at 4 (OR=0.14; 95% CI: 0.05–0.36) or at 9 months of age
(OR=0.05; 95% CI: 0.02–0.16).
Discussion
This study in Ango ´nia district has evaluated the effectiveness of
OFZ treatment in pigs, as a strategy to control T. solium
cysticercosis in a highly endemic area in which pigs are constantly
exposed to the parasite. A substantial benefit of treating pigs with
OFZ using the single oral dose of 30 mg/kg body weight was
clearly demonstrated, since the prevalence and incidence in groups
of treated pigs was significantly lower compared to the group of
untreated pigs. All pigs that were infected at the time of treatment
with OFZ were found negative in the subsequent sampling round
(5 and 3 months later for T1 and T2, respectively). Interestingly,
this result was observed in animals raised under constant exposure
to T. solium eggs [26] but were in keeping with previous studies
conducted under controlled settings reporting a clear effect of
OFZ in killing cysts when given as a single dose of 30 mg/kg [22–
24,29].
A significant number of negative control pigs (51/79) got
infected whereas 1 of the 2 infected pigs treated at 4 months and
none of the 18 infected pigs treated at 9 months were found re-
infected at the end of the study. The latter result is very convincing
of induction of a high level protective immunity whereas the
former may raise some speculations. One could argue that the
result may be explained by differences in individual immune
responsiveness or even exposure, as animals become susceptible to
new infections after treatment. Also, it can be speculated that there
were false serological results or even cross reactions with T.
hydatigena infection, though this is unlikely as none of the 51 pigs
found infected in control group had fluctuating positivity and all
pigs (7/30) that were found positive at necropsy had no T.
hydatigena cysticerci. Nevertheless, in accordance with our findings,
naturally infected pigs treated with OFZ under field conditions
were not re-infected for at least 3 months. These results support
conclusions from previous studies [23,25] and speculations that
treated pigs remain immune to re-infection for at least 12 weeks
[24].
However, although the effectiveness of OFZ can be regarded as
good, the prevalence and incidence of T. solium cysticercosis in T1
pigs increased during the study period. The observed increase after
treatment is most likely related to new infections in animals being
fully susceptible at the time of treatment. Indeed, nearly all of the
T1 pigs (51/54) were negative by Ag-ELISA at the time of
treatment, thus being at risk of infection. On the other hand, the
prevalence and incidence of T. solium cysticercosis in T2 pigs
reduced significantly from treatment at 9 months to 12 months of
age. This strategy, although also involving possible treatment of
uninfected pigs, showed better results and the potential to be used
as a control strategy for T. solium cysticercosis in our settings
considering the lifespan of pigs is usually less than one year. Our
findings are in line with an earlier field study that showed a clear
effect of mass treatment with OFZ at 30 mg/kg body weight in
decreasing the prevalence and incidence of porcine cysticercosis,
however that study had utilised an antibody-detection method
which measures exposure and not necessarily active infection [30].
The significant decrease in the risk of porcine cysticercosis
infection at the age of 12 months observed in this study if pigs were
treated with OFZ, either at 4 or 9 months of age, was observed in
a context of poor living conditions in the study area, where most
pigs were left to roam freely and no other control interventions
were implemented. This finding, and the low cost of the drug
(approximately 0.018 USD/dose), corroborates previous conclu-
sions considering OFZ as a potential effective control tool for
porcine cysticercosis in resource-poor endemic areas [22–24,29].
However, it should be borne in mind that many strategies to
control T. solium cysticercosis in developing countries have shown
promising results [7,13,21,31,32] but none has fully succeeded up
to date, mainly due to poor socioeconomic and sanitary conditions
[7,13]. Control measures targeting pigs alone would be ineffective
as they cannot prevent the spread of cysticercosis in humans and
pigs [21,33,34], thus there is a need for integration with other T.
solium control strategies in the long term [34–36]. Moreover,
inexpensive and reliable diagnostic tests in live animals are needed
for monitoring the effect of interventions in endemic countries.
The Ag-ELISA used in this study, though considered very sensitive
[37] may have drawbacks in monitoring the effectiveness of
treatment in pigs as cysticercal antigen levels take some time to
disappear from circulation after treatment depending on the
intensity of infection [24]. Furthermore, the technique may not
detect brain cysts [24,25], though in our study brain cysts were
only found in some of the control pigs, and currently it does not
allow differentiating T. solium from T. hydatigena cysticerci [18].
The results presented in this study showed that OFZ treatment
in the last part of the pigs’ fattening period is effective to control
porcine cysticercosis but is not a stand-alone approach because in
high endemic areas a certain number of animals will inevitably get
infected after treatment and before slaughter. Although effective,
its strategic use as a control tool in T. solium endemic areas should
Table 3. Number of pigs with Taenia solium cysts at
necropsy.
Findings at necropsy Control group T1 group T2 group
One or more viable cysts 6 1 0
No cysts 8 7 8
Total 14 8 8
doi:10.1371/journal.pntd.0001651.t003
Table 4. Multiple logistic regression analysis for factors
associated with prevalent cases of porcine cysticercosis.
Factor Odds Ratio 95% CI p-value
Treatment group Control 1
OFZ-T1 0.14 0.05–0.36 ,0.001
OFZ-T2 0.05 0.02–0.16 ,0.001
Sex Female 1
Male 1.02 0.47–2.22 0.95
Free range No 1
Yes 1.76 0.38–8.20 0.47
Village Camuetsa 1
Campessa 1.12 0.34–3.68 0.85
Ndaula 1.09 0.40–2.95 0.87
Lilanga 1.06 0.23–4.81 0.94
doi:10.1371/journal.pntd.0001651.t004
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formulation, regimen of administration, safety and marketing of
pigs. Despite these concerns and considering that any strategy to
control T. solium by targeting pigs has a potential to provide
economic incentives to poor smallholder pig farmers, treatment of
pigs with OFZ, if integrated with other control measures such as
treatment of human tapeworm carriers, ending open human
defecation, education, and community-based inspection and sales
restrictions, should be considered an important, cost-effective
measure to reduce the transmission of T. solium infections in
endemic low-income areas.
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